GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EXMceuticals Inc (STU:9OM1) » Definitions » YoY EBITDA Growth

EXMceuticals (STU:9OM1) YoY EBITDA Growth : 53.33% (As of Mar. 2021)


View and export this data going back to 2019. Start your Free Trial

What is EXMceuticals YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. EXMceuticals's YoY EBITDA Growth for the quarter that ended in Mar. 2021 was 53.33%.

EXMceuticals's EBITDA per Share for the three months ended in Mar. 2021 was €-0.02.


EXMceuticals YoY EBITDA Growth Historical Data

The historical data trend for EXMceuticals's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EXMceuticals YoY EBITDA Growth Chart

EXMceuticals Annual Data
Trend Jun11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32.56 75.86 -57.14 -2,509.09 46.69

EXMceuticals Quarterly Data
Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 55.88 -10.20 40.00 50.00 53.33

EXMceuticals YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

EXMceuticals's YoY EBITDA Growth for the fiscal year that ended in Jun. 2020 is calculated as:

YoY EBITDA Growth (A: Jun. 2020 )
=(EBITDA per Share (A: Jun. 2020 )-EBITDA per Share (A: Jun. 2019 ))/ | EBITDA per Share (A: Jun. 2019 ) |
=(-0.153--0.287)/ | -0.287 |
=46.69 %

EXMceuticals's YoY EBITDA Growth for the quarter that ended in Mar. 2021 is calculated as:

YoY EBITDA Growth (Q: Mar. 2021 )
=(EBITDA per Share (Q: Mar. 2021 )-EBITDA per Share (Q: Mar. 2020 )) / | EBITDA per Share (Q: Mar. 2020 )) |
=(-0.021--0.045)/ | -0.045 |
=53.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


EXMceuticals YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of EXMceuticals's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


EXMceuticals (STU:9OM1) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
421 7th Avenue S.W., 30th Floor, Calgary, AB, CAN, T2P 4K9
EXMceuticals Inc is a bio-science company that believes in the potential health and wellness benefits of hemp and cannabis. EXM is an emerging player in the market, with ambition and potential to become the suppliers of highest-grade cannabis ingredients. It is creating an industrial-scale, GMP, Pharmaceutical Grade Extraction and Refining facility inside the European Union, near Lisbon Portugal. It has an existing and licensed cannabis R&D facility and pilot refinery in Lisbon Portugal. EXM is targeting the B2B marketplace and will supply pure ingredients and API's to the pharmaceutical, medicinal and wellness industry.

EXMceuticals (STU:9OM1) Headlines

No Headlines